Mahan Salehi Mubashar Iqbal Asha Dube Amer AlJoudeh Frank Edenborough
10.1016/j.rmcr.2021.101553
Respir Med Case Rep
2021 Nov 10;34:101553.
alp, alkaline phosphatase alt, alanine transaminase ast, aspartate transaminase adverse effect cf, cystic fibrosis cftr modulators cftrm, transmembrane regulator protein modulator cmv, cytomegalovirus ebv, epstein-barr virus fev1, forced expiratory volume ggt, gamma-glutamyl transferase hepatic necrosis liver injury severe transaminitis vzv, varicella-zoster virus
CC BY-NC-ND
https://pubmed.ncbi.nlm.nih.gov/34815934/
Case Reports
PMC8593462
34815934
Delayed hepatic necrosis in a cystic fibrosis patient taking Elexacaftor/Tezacaftor/Ivacaftor (Kaftrio)
2021